Senores Pharmaceuticals
SENORESNSE

Senores Pharmaceuticals

₹1,404.0019.00 (1.37%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,368.70
Today’s high
1,410.00
52 week low
601.10
52 week high
1,509.80
Open price
1,385.00
Previous close
1,385.00
Live volume
1,30,976
Lower circuit
1,123.20
Upper circuit
1,684.80

Fundamentals

Market Cap
₹6,471Cr
ROE
12.36%
P/E Ratio(TTM)
53.25
EPS(TTM)
26.39
P/B Ratio
6.93
Dividend Yield
0.00%
Industry P/E
36.57
Book Value
202.72
Debt to Equity
0.37
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹193
+8.14%
Profit (Cr)
₹36.67
+9.20%
050100150200
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+53%
3Y CAGR+206%
Profit growthValue
1Y (TTM)+104%
3Y CAGR+289%

About

Senores Pharmaceuticals Limited manufactures pharmaceutical formulations and active pharmaceutical ingredients (APIs).;
CEO/MD
Swapnil Jatinbhai Shah
Founded in
2017
NSE symbol
SENORES

Shareholding Pattern

Jun '26
Mar '26
Dec '25
Sep '25
Jun '25
Promoters
45.78%
Retail And Others
41.04%
Other Domestic Institutions
6.51%
Foreign Institutions
3.67%
Mutual Funds
3.00%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹875.70
-0.40 (0.05%)
L
    H
    21,693.3832.754.6
    PfizerPFIZER
    ₹4,593.30
    +15.40 (0.34%)
    L
      H
      20,997.9829.075
      ₹1,470.00
      +6.70 (0.46%)
      L
        H
        20,359.2631.445.22
        ₹8,088.50
        +34.00 (0.42%)
        L
          H
          20,225.50107.8523.17
          Livesquawk
          Senores Pharma schedules Q1 earnings call for July 27 at 5:15 PM.
          Livesquawk
          Senores Pharma Q4 EBITDA rises to 475M vs 194M YoY. EBITDA margin expands to 27.1% from 17% YoY.
          2026
          14
          May
          Annual Result
          Release date
          20
          Jan
          Quarterly Result
          Release date
          2025
          6
          Nov
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks